Prostate cancer advances help extend a patient's life

September 11, 2018 | Dory Benford

Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.

Continue Reading

CIRM Awards City of Hope Researchers $3.7 million to Develop Glioblastoma Clinical Trial

September 28, 2018 | Letisia Marquez

California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.

A breakthrough treatment for melanoma metastasized to the brain

September 6, 2018 | Maxine Nunes

A remarkable new study, groundwork for which was begun by City of Hope oncologist Kim Margolin, M.D., brings new hope to people with melanoma that has metastasized to the brain.

For One Patient with Neuroendocrine Tumors, Being First Matters

July 12, 2018 | Wayne Lewis

Lynn DeGroot was the first patient at City of Hope to receive a targeted therapy called Lutathera PRRT following recent FDA approval for counteracting certain neuroendocrine tumors, and one of the first patients nationwide to receive the treatment.

‘This Is a Curable Cancer’: New Treatment Options for Sarcoma

July 9, 2018 | Kevin Chesley

Sarcoma affects the connective tissues of the body. These are uncommon cancers, but City of Hope’s Brooke Crawford, M.D, knows the options available for her patients facing all of these varied sarcomas.

City of Hope Awarded $3.7 million to Develop Glioblastoma Clinical Trial

June 29, 2018 | Letisia Marquez

California Institute for Regenerative Medicine has awarded City of Hope $3.7 million to develop a phase 1 clinical trial for glioblastoma patients, which would genetically alter blood stem cells to better tolerate chemotherapy.

The Gold Standard: City of Hope’s Pediatric Musculoskeletal Tumor Program

June 16, 2018 | Travis Marshall

Pediatric musculoskeletal tumors and sarcomas are so rare and diverse that it’s almost impossible for a single physician to effectively treat them. But City of Hope is uniquely equipped to provide rapid and comprehensive treatment for these highly aggressive cancers.

Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Meet Our CAR T Team: Christine Brown, Ph.D.

January 26, 2018 | Abe Rosenberg

Christine Brown, Ph.D., co-leads the T Cell Therapeutics Research Laboratory, along with Stephen J. Forman, M.D., which to date has treated more than 100 patients in seven clinical trials, with aggressive goals of opening four new clinical studies within the year.

Four symptoms not to ignore if you’ve had cancer

January 23, 2018 | Denise Heady

Neurosurgeon and scientist Rahul Jandial says some symptoms should never be ignored by former cancer patients. More and more people are surviving cancer, thanks to advanced cancer treatments and screening tools.